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Vulnerable periods during the development of the nervous system are sensitive to environmental
insults because they are dependent on the temporal and regional emergence of critical
developmental processes (i.e., proliferation, migration, differentiation, synaptogenesis, myelination,
and apoptosis). Evidence from numerous sources demonstrates that neural development extends
from the embryonic period through adolescence. In general, the sequence of events is comparable
among species, although the time scales are considerably different. Developmental exposure of
animals or humans to numerous agents (e.g., X-ray irradiation, methylazoxymethanol, ethanol, lead,
methyl mercury, or chlorpyrifos) demonstrates that interference with one or more of these
developmental processes can lead to developmental neurotoxicity. Different behavioral domains
(e.g., sensory, motor, and various cognitive functions) are subserved by different brain areas.
Although there are important differences between the rodent and human brain, analogous structures
can be identified. Moreover, the ontogeny of specific behaviors can be used to draw inferences
regarding the maturation of specific brain structures or neural circuits in rodents and primates,
including humans. Furthermore, various clinical disorders in humans (e.g., schizophrenia, dyslexia,
epilepsy, and autism) may also be the result of interference with normal ontogeny of developmental
processes in the nervous system. Of critical concern is the possibility that developmental exposure
to neurotoxicants may result in an acceleration of age-related decline in function. This concern is
compounded by the fact that developmental neurotoxicity that results in small effects can have a
profound societal impact when amortized across the entire population and across the life span of
humans. Key words: abnormal neurological development, apoptosis, behavioral testing
methodology, delayed neurotoxicity, differentiation, migration, myelination, neurobiological
substrates of function, neuronal plasticity, neurotrophic factor, primate, rodent. - Environ Health
Perspect 108(suppl 3):511-533 (2000).
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The vulnerability ofthe developing brain is
dependent on two main exposure issues. The
first factor relates to whether an agent or its
active metabolite(s) reaches the developing
nervous system, and the second factor relates
to the period ofexposure. Exposure to envi-
ronmental toxicants coincident with the
ontogeny ofdevelopmental processes is more
likely to cause adverse effects ifthey interfere
with the cascade of these developmental
processes. In general, if exposure occurs
before or after an organ develops, it is less
vulnerable to perturbation than ifexposure
occurs duringdevelopment ofthat organ.
It is critical for the risk assessment ofenvi-
ronmental chemicals that we have a good
understanding of the time lines of normal
neural development in humans and other
species used in toxicological testing. This
understanding should include both pharma-
cokinetic and pharmacodynamic factors that
may differ across species. Both species- and
age-related differences in pharmacokinetic
parameters are out ofthe scope ofthis review
paper, but other papers have attempted to
describe these parameters in a limited way
with pesticides (1-5), metals (6-10), and a
solvent (11).
There is general recognition that the devel-
oping nervous system is qualitatively different
from the adult nervous system. The normal
ontogeny ofneural development in rodents is
different from humans because rodents have
considerable postnatal development and
humans have considerably more prenatal mat-
uration oftheir nervous systems. These differ-
ences may be confounded with differences in
the route ofexposure during critical periods of
nervous system development and thus differ-
ences in vulnerability between developing ani-
mals and humans (e.g., lactational transfer
during the first postnatal week in rodents and
transplacental transfer during the third
trimester inhumans).
Key aims ofthis article are to characterize
the profiles of developmental processes,
describe similarities and differences in win-
dows ofvulnerability between rodents and
humans, and describe similarities and differ-
ences in effects after perturbations ofdevelop-
mental processes in humans and animal
models, including rodents and monkeys. The
brain areas subserving various behavioral
functions are described for human infants
and the ontogeny of these specific structures
is discussed in the context of the effects of
lesions in nonhuman primates with altered
performance on these tasks. This will further
our understanding ofdevelopmental neuro-
toxicology, improve our ability to predict
adverse outcomes in animals, and assist in the
extrapolation of these adverse outcomes to
risks to human health.
Development ofthe Brain
in Utero
The cell precursors ofthe brain and spinal
cord, which compose the central nervous sys-
tem (CNS), begin to develop early in
embryogenesis through the process called
neurulation. The notochord, which is a cellu-
lar rod that defines the primitive axis ofthe
embryo, will be incorporated into the verte-
bral system. The notochord induces the over-
lying ectodermal tissue to form the neural
plate at approximately 2 weeks ofgestation in
humans. This overlying ectodermal tissue
gives rise to the CNS. In humans on approxi-
mately gestational day (GD) 18, the neural
plate invaginates along its central axis to form
the neural groove with neural folds on each
side. By the end ofthe thirdweekofgestation
in humans, the neural folds have begun to
move together and fuse, forming the neural
tube near the anterior end ofthe notochord;
this fusion progresses both cranially and cau-
dally in a zipperlike manner. The neural tube
then separates from the overlying ectoderm,
which becomes a contiguous surface over the
back ofthe embryo and differentiates into the
epidermis of the skin. As the neural tube
forms, a population ofcells separates from the
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surface ectoderm at the apex of the neural
folds to form the neural crest, which will give
rise to the sensory ganglia ofspinal and cra-
nial nerves, Schwann cells (the cells covering
peripheral nerves), the meningeal covering of
the brain and spinal cord, and some skeletal
and muscle components ofthe head, among
other structures. The neural tube begins to
close in the area ofthe hindbrain above the
origin ofthe notochord and proceeds anteri-
orly and posteriorly, creating a caudal-to-
rostral gradient in development ofthe brain.
Neural tube formation is complete at approx-
imately GD 10.5-11 in rats and from GD 26
to 28 in humans; the anterior neuropore
closes first (rats GD 10.5, humans GD
24-26) and the posterior neuropore closes
later (rats GD 11.3, humans GD 25-28)
[reviewed by DeSesso (12)].
Interruption of neural development dur-
ing this early period can result in severe abnor-
malities of the brain and spinal cord. Spina
bifida (divided spine) results from defective
induction ofmesoderm around the notochord
that forms the osseous bone of the spine.
There are several types ofspina bifida, which
range from anomalies in the vertebrae ofno
significance to severe defects in the spinal cord
or brain. Extreme cases ofspina bifida (i.e.,
anencephaly) lead to failure in the closure of
the neural tube and severe defects in the spinal
cord or brain. For example, failure of neural
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Figure 1. Timelines of developmental processes in the nervous system of rats compared to timing of fertilization,
organogenesis, and histogenesis. Modified from Vorhees (15) and reprinted with permission of Plenum Press.
tube closure results in extroversion of the
neural tissue, which then degenerates as in
anencephaly, wherein the brain is represented
by a mass ofdegenerated neural tissue exposed
on the surface ofthe head. It has recently been
established that an increased intake offolic
acid during early gestation or prenatally
decreases the prevalence ofneural tube defects
in offspring (13). Increased risk for spina
bifida may depend on the mother and/or fetus
being homozygous for specific forms of
enzymes involved in folate metabolism (14).
Beginning early in the second week ofges-
tation in rodents (GD 7 in mouse, GD 9.5 in
rats) and the first month of gestation in
humans, specific areas ofthe CNS begin to
form with the neurogenesis and migration of
cells in the forebrain, midbrain, and hindbrain.
There follows a sequence ofdevelopmental
processes including proliferation, migration,
differentiation, synaptogenesis, apoptosis, and
myelination [Figures 1 (15) and 2 (16)].
Alterations in these processes can result in
severe congenital abnormalities ofthe nervous
system of humans, with a frequency of
0.74-1.89 cases per 1,000 births according to
a recent survey (17). These overt abnormali-
ties include conditions that produce
extremely severe functional deficits and which
may be incompatible with life, including
anencephaly, hydrocephaly, and herniation of
the spinal cord. Significant risk factors associ-
ated with these conditions include parental
age, toxemia in the mother, threatened inter-
ruption ofthe pregnancy, and prematurity or
intrauterine hypotrophy. A literature survey
of > 70 studies from various countries (18)
found that the incidence ofmental retarda-
tion is approximately 4 per 1,000 births,
although, as stated by the authors, the true
prevalence is difficult to determine.
Regional Development ofthe
Rodent and Primate Brain
In general, regional development ofthe rodent
brain proceeds on a timeline ofdays versus
weeks to months in humans, although gross
regional development ofthe brains ofrodents
and humans is similar. In the case ofspecific
structures, however, there may be differences
in the relative mass and/or volume ofa specific
structure between species. Examples include
the relatively larger mass ofthe neocortex and
visual system in humans versus that of rats.
Conversely, the relative mass ofthe olfactory
system is larger in rodents than in humans.
The gradients of maturation of developing
regions of the nervous system in rats and
humans follow the same general sequence,
with more caudal regions like the hindbrain
{metencephalon and myelencephalon [Figure
3 (15]) developing earlier than the more ros-
tral areas like the forebrain (telencephalon and
diencephalon) and with the more medial
Environmental Health Perspectives * Vol 108, Supplement 3 * June 2000
Figure 2. Comparison of timelines for developmental processes in humans. The prenatal period is scaled in months
and the postnatal development is scaled in years. Adapted from Herschkowitz et al. (16) and reprinted with permis-
sion of Hippokrates Verlag GmbH.
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Figure 3. Development of the brain vesicles and subsequent brain divisions of the mammalian brain. (A) and (B) The development of the three primary brain vesicles on GD 10.5 in
rats and GD 26 ± 1 in humans. The corresponding shading between panels illustrates the earlier origins of different regions from the three original brain vesicles with a horizontal
and lateral view, respectively. (C) and (D) The more mature brain with five brain vesicles: the horizontal and lateral views correspond to GD 11.5 in rats and GD 33 ± 1 in humans.
(E) The lateral view shows the migratory paths from the more central ventricular zone and gradients maturation of the neocortex (see arrows). (F) The midsagittal view of the brain
and spinal cord, with the major divisions delineated and the continuity of the ventricles noted; the formation of the choroid plexus corresponds to GD 13.5 in rats and GD 48-51 in
humans. Adapted from Carpenter and Sutin (19) and reprinted with permission of Williams and Wilkins.
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aspects ofthese structures maturing earlier
than more lateral aspects. The pons, medulla,
and cerebellum make up the hindbrain. The
pons and medulla include brainstem motor
and sensory nudei that mature relatively early
and, for the most part, coincident with cranio-
facial development during the embryonic
period ofboth rats (GD 10-16)- and humans
(3-7.5 weeksofgestation). Although theabove
generalizations are useful, there are exceptions
to the rostral-to-caudal gradients. One excep-
tion is apparent in the delayed development of
the cerebellum relative to the early develop-
ment ofother hindbrain structures. The cere-
bellum is a caudal structure that arises from the
dorsal lips of the hindbrain and develops
largely later in brain development in both rats
and humans than the other cranial nerve
nuclei ofthe hindbrain. The midbrain or mes-
encephalon includes dorsally the tectum and
ventrally the tegmentum. The tectum includes
the superior and inferior colliculus, which pro-
liferate and differentiate during the fetal and
embryonic periods in rats andhumans, respec-
tively. The tectum continues to develop into
the postnatal period with increased synaptoge-
nesis to and from their principal efferent and
Is:
Figure 4. Growth and development can be assessed
crudely with measures of (Al body, (BI brain, and (C)
regional weights. The data depicted illustrates weights
(mass) of female long-Evans rats during postnatal devel-
opment. Regional weights are from freehand dissections
of each region (brainstem is defined as the pons and
medulla). Cerebellum includes both the hemisphere and
the flocculonodular lobes. Data are expressed as means
FSE. Adapted from Rarone et al. l2LA and renrinted with
permission of Intox Press, Inc.
afferent structures. The diencephalon, which
includes the hypothalamic and thalamic
nudei, develops during the late embryonic and
early fetal periods in both rats and humans.
The forebrain cortical structures ofthe neocor-
tex and hippocampal formation develop pri-
marily during the fetal period ofboth rats and
humans, with some proliferation ofglia and
microneurons continuing into the postnatal
period. Differentiation and synaptogenesis
within and between these cortical structures
and their subcortical afferents continue into
the postnatal period in both rats and humans.
A significant difference between the rodent
and human (and other primate) brains can be
observed in the size and contourofthe neocor-
tex. Rodents have a smooth (lissencephalic)
cerebral cortex with a relatively small neocor-
tex. Humans, on the other hand, have brains
with a highly convoluted surface (gyren-
cephalic brain) resulting from the enormous
phylogenetic expansion ofthe neocortex. The
ontogeny ofspecific regions ofthe brain incor-
porate the timely progression and completion
of these developmental processes. This
sequence for a specific region may generalize
readily between rodents andhumans; however,
at the level of integration and connectivity
among structures, with theexception ofsensory
systems, it is often only speculative to extrapo-
late results from animals to humans because of
thelimited number ofcomparative studies.
The brain undergoes tremendous growth
beginning early in gestation and continuing
into the postnatal period. In rodents,
regional and total brain weights are crude
estimates ofbrain development that continue
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to increase during the postnatal period
[Figure 4 (20)]. In humans, gross measures
ofbrain growth increase for at least 2-3 years
after birth. The growth rate ofthe brain as a
whole, as measured by change in volume,
peaks approximately 1.1 years after concep-
tion or approximately 4 months after birth
(Figure 5). The growth rate of the human
diencephalon peaks about the time ofbirth,
whereas the peak rate ofgrowth ofthe cere-
bellum is approximately 1.3 years after con-
ception (i.e., 7 months of age) (21). It is
important to remember that changes in vol-
ume represent only crude measures ofbrain
development. In addition, it is noteworthy to
emphasize that birth does not represent a
divide signifying an absolute change in brain
development or the end ofany developmen-
tal processes. Thus, various parts ofthe brain
develop at different times and have different
windows ofvulnerability, both prenatally
and postnatally, based on the temporal and
regional maturation mediated through a
multitude ofdevelopmental processes.
Proliferation
Neurogenesis is a highly regulated process
that differs depending on the location in the
anterior to posterior gradient in the neuraxis.
Figure 6 provides a broad overview of the
neurogenesis in the major structures ofthe
brain and spinal cord. Bayer et al. (22) pro-
vide a much more detailed description ofthe
development of specific brain structures.
Figure 6 depicts the time during fetal devel-
opment when neurogenesis occurs in each
structure: in other words, when the neurons
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Figure 5. The regional growth rate of the human brain and different regions during prenatal and postnatal develop-
ment scaled for both days and years after conception. Growth rate of the entire brain, telencephalon, diencephalon,
and rhombencephalon including cerebellum during the development of humans. These curves were derived from four-
parametric logistic functions. Adapted from Koop et al.121) and reprinted with permission of S. KargerAG.
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which will eventually comprise that structure
are born. Within each broad brain region var-
ious nuclei and other substructures also
develop according to apredictable timetable.
Both the amount and temporal windows
ofneurogenesis vary within different regions
ofthe brain. These incongruities can be exem-
plified bycomparing thedevelopment ofthree
cortical regions: the neocortex, hippocampus,
and cerebellum. Cytogenesis in the neocortex
is dependent on the exponential proliferation
of a multipotent population ofpseudostrati-
fled cells localized in the ventricular zone, as
concluded by the Boulder Committee study
ofproliferation and neural development (23).
In the rat, this ventricular zone is histologi-
cally distinct beginning around GD 12.
Shortly thereafter, the anatomically superficial
subventricular zone is distinguishable. This is
a secondary proliferative population of cells
that also contributes appreciably to the ulti-
mate cell population of the mature neocortex
(24). The most expansive phase ofprolifera-
tion in the rat ventricular and subventricular
zones occurs roughly between GD 13 and 18,
although some neocortical cells may remain
mitotic until near parturition in rodents [GD
21/22; reviewed by Bayer and Altman (25)
and Rakic and Caviness (26)]. In addition,
interspecies comparisons between rodent and
human proliferation and migration demon-
strate that the patterns ofthese processes and
the progression ofregional development are
relatively parallel, although the time scales are
substantially different (days for rodents and
weeks to months for humans) (22).
The hippocampal formation arises from
the morphogenetic folding ofthe medial pro-
liferative zone ofthe cortical plate to form the
subiculum, pyramidal cell fields, and subse-
quently the dentate gyrus. The dentate gyrus,
which forms prenatally, displays continued
postnatal proliferation ofgranule cells in the
hippocampal formation ofboth rodent and
humans (27). The proliferation of the cere-
bellum takes place in different phases, with
the primary proliferative cells migrating to
the rhombiclips ofthe primordial cerebellum
during the fetal period and then migrating to
a secondary proliferative zone in the external
granule layer of the cerebellum. This sec-
ondary wave ofproliferation in the cerebellar
cortex occurs postnatally in rodents and dur-
ing the last trimester in humans but also
continues postnatally.
Numerous environmental agents can alter
neural proliferation. Classic experimental tools
forstudying the effects ofaltered developmen-
tal proliferation have included administration
of antimitotic agents like ionizing radiation
[reviewed by Bayer and Altman (25)] and
methylazoxymethanol (MAM) (28) during
critical windows ofdevelopment. Studies with
antimitotic agents have clearly demonstrated
that when proliferation is actively occurring in
a given region ofthe brain it is vulnerable, but
when cell proliferation ceases, the brain is
more resilient to these agents. More recently, a
number ofreports have focused on the effects
ofethanol on proliferation in the fetal brain of
experimental animals [reviewed by Guerri
(2-95]. Thecapacity ofethanol to alterprolifer-
ation in the ventricular and subventricular
zones has been clearly demonstrated in
rodents (30). The organophosphorus pesticide
chlorpyrifos appears to alter proliferation after
developmental exposure in rodents (31-34).
In the case ofmethyl mercury it appears that
proliferation is affected in both experimental
animals (35,36) and humans (37).
Migration
Migration ofrecently proliferated cells (GO
cells) from the ventricular zone and other ger-
minal layers occurs radially in the medial/dor-
sal neocortex and tangentially in other regions
ofthe forebrain such as the olfactory bulb and
lateral neocortex (38). In the neocortex, for
example, the mature cortical plate has histo-
logically distinct laminae, classified as layers I
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through VI, and a subplate (layer VII). Layer
VI is the deepest layer ofthecortical plate; i.e.,
it is closest to the geometric center of the
brain. Layer I is the most superficial layer; it is
the outward-most subpial layer. The forma-
tion oflayers VII and I is distinct from the cell
migrations that populate layers VI through II
(39). Cells from the ventricular zone populate
layers VI-II in an inside-out fashion, meaning
that the deeper layers form first (40). By GD
16 and 17 in the rat, the first cells are arriving
in the area that will ultimately form the lami-
nae ofthe cortical plate. Through the remain-
der ofgestation, the cortical plate gets thicker
as more cells migrate from the ventricular
zone. In the days before parturition, layer VI
is histologically distinct from the remainder of
the maturing cortical plate. On postnatal day
(PND) 5 ofthe rat, layers VI and V are read-
ily distinguishable, but layers IV-II are not as
dearlydefined. Thesesuperficial layers (IV-II)
are more distinct in adulthood but never con-
stitute more than one-third ofthe cortical
width. The remaining two-thirds ofthe corti-
cal width is split approximately equally
between layers VI and V, depending on the
neocortical region ofstudy (41). In addition
to the migration of neurons to the cortical
plate, other factors modify the lamination of
the neocortex including cell packing density,
cell size, extracellular matrix, gliogenesis,
myelination, and synaptogenesis ofcortical
afferents/efferents, all ofwhich contribute to
thefinal differentiation ofthis neural structure.
In general, these cortical areas are homologous
between species, with notabledifferences in the
relative size ofstructures, cell number, and
extentofextracellularneuropil.
It is important to note that when pro-
liferation is disrupted, migration is often also
affected. This can be demonstrated after
exposure to X-ray irradiation or MAM, in
which ectopias are a prominent pathological
feature. In addition, a number ofknown
developmental neurotoxicants like ethanol
(42) and methyl mercury affect both prolifer-
ation (35-37) and migration (43,44) after
gestational exposures. Methyl mercury dis-
rupts migration in both humans (43) and
animal models (44).
Differentiation
Differentiation ofneuroblasts can be defined
as the process ofdedicated expression ofa ter-
minal phenotype. Even though proliferation,
migration, and differentiation are investigated
and discussed separately, the initial phase of
differentiation likely begins as soon as neu-
ronal precursors complete their last division
and are primed for migration to the cortical
plate (45-47). As neurons migrate, the inter-
play ofextracellular and intracellular cues ini-
tiates the expression ofparticular genes that
will influence the neuronal or glial phenotype.
Particular phenotypic characteristics such as
shape, size, polarity, and expression ofneuro-
transmitters and receptors, among other
features, allow distinction among differenti-
ated neurons and glia. Numerous examples
appear to support the contention that envi-
ronmental influences affect this developmen-
tal process. Environmental agents that affect
differentiation ofthe nervous system run
across a broad gamut of chemical classes
including ethanol (48-51), nicotine (52-57),
methyl mercury (58), and lead (59-61). It is
important to note that perturbations that alter
neural proliferation and migration often result
in altered differentiation. This has been illus-
trated in studies ofpunctate exposure to X-ray
irradiation in rodent models (62,63).
Synaptogenesis
Synapses, the neurobiological substrates of
almost all cell-to-cell communication (64),
mature over the first 3 weeks during the post-
natal period in rats (65) and through adoles-
cence in monkeys (66) and humans (67).
Synaptogenesis consists ofbiochemical and
morphological changes in both the pre- and
postsynaptic elements. Physicochemical com-
patibility ofthese elements and correct timing
with competitive exclusion ofinappropriate
connections are essential for the maturation of
synaptic connections [reviewed byJacobson
(65)]. Within each region ofthe nervous sys-
tem, the schedule by which synapses form is
rigidly followed.
Direct measurement ofsynaptogenesis in
the developing brain requires ultrastructural
analysiswhich, althoughhighlyspecific, is only
practical under specific conditions where the
time and location ofa potential alteration of
this process is in question. Ultrastructural
analysis illustrates the developmental increase
in synaptic densities of the rat neocortex
[Figure 7 (68)]. Other methods ofstudying
synaptogenesis, although less definitive,
include indirect approaches such as looking at
neurochemical and immunohistochemical
markers for synaptic proteins [e.g., synapsin 1
(69,70)] and related proteins ofpresynaptic
[e.g., synaptotagmin, synaptophysin, and
GAP-43 (71)] or postsynaptic origin [e.g.,
neurogranin and MAP2 (72)]. A less direct
technique forquantifying synaptogenesis is the
morphometric measurement oflayer widths.
Measurements ofthe widths oflayers that are
predominantly synaptic zones (e.g., layer 1 of
neocortex, the molecular layers ofboth the
hippocampal dentate gyrus and cerebellum)
during early periods postnatally (i.e., PND
10-12) in rats can provide an indirect estimate
ofalterations in synaptogenesis and dendritic
elaboration. Morphometric measurements of
synaptic zones in neocortex (58), hippocampus
(73), and cerebellum (74) can reveal perturba-
tions ofthisdevelopmental process.
Exposure during critical periods ofdevel-
opment to a number of agents, including
MAM (75), X-ray irradiation (76), ethanol
(77,78), lead (79-82), methyl mercury (83),
triethyltin (84), inhibitors ofserotonin syn-
thesis (85), parathion (86), permethrin, diiso-
propyl fluorophosphate, and polychlorinated
biphenyl (PCB) mixtures (87), have all been
implicated in altered synaptogenesis. In gen-
eral, findings from these rodent studies indi-
cate that the effects ofthese agents are more
restricted to synaptogenesis when they are
administered postnatally during the first and
second week ofbrain development when this
process is occurring rapidly.
Gliogenesis and Myelination
There are numerous supportive cells in the
nervous system called glia, including micro-
glia, radial glia, astroglia, oligodendroglia, and
Schwann cells, that are integral for the normal
development and function ofthe nervous sys-
tem (88,89). Radial glial and microglial devel-
opment occurs in parallel with neurogenesis in
most structures ofthe brain, and in the case of
microglia may be partially derived from extra-
brain sources (90,91). Radial glia provide a
scaffold for radial migration ofneuroblasts
(92,93). Microglia function as brain macro-
phages to clean up dead cells and cellular
debris after apoptosis (91). Oligodendrocytes
and astrocytes, on the other hand, develop
well after the initial waves ofneurogenesis and
their differentiation often lags behind that of
the neurons in a given structure (94,95)
(Figure 8). Differentiation ofoligodendrocytes
follows axogenesis and is believed to be medi-
ated by complex trophic signals between neu-
rons and these glia. Most astrocytes proliferate
and differentiate well after much ofthe migra-
tion and differentiation ofneuronal cells are
completed, although some are believed to arise
from the radial glia (88). In simplistic terms,
astrocytes function to maintain ionic and
trophic balance of the extracellular milieu,
whereas oligodendrocytes and Schwann cells
insulate and myelinate axons ofneurons in
the CNS and peripheral nervous system,
co
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Figure 7. Synaptogenesis determined from ultrastruc-
tural analysis of layer 1 of the rat parietal cortex. The
x-axis scale is in days. Adapted from O'Callaghan (69)
and reprinted with permission of Raven Press.
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respectively. The functional role ofastrocytes
and microglia may be transformed after ner-
vous system damage (96,97); both cell types
become reactive after insults to the nervous
system. This reactive gliosis is unquestion-
ably a pathological index when observed in
the adult nervous system. In the developing
nervous system, neural damage may not initi-
ate the same degree ofreactive gliosis depend-
ing on the timing ofthe insult which, in the
case ofastrocytes, could precede their major
phase ofproliferation and differentiation.
Perturbations ofthe development ofglial pro-
liferation, migration, and differentiation can
also result in adverse consequences (98,99).
Elaboration ofmyelin occurs later in devel-
opment than proliferation and migration of
neuronal populations (100). Malnutrition can
affectmyelination, and this process isespecially
vulnerable during late gestational development
in humans and postnatally in rodents.
Alterations in myelination can have a persis-
tent adverse outcome resulting from postnatal
malnutrition and alterations in thyroid hor-
mone homeostasis even though somatic
growth may recover [reviewed by Wiggins
(101)]. Effects on myelination are readily
observed after malnutrition or endocrine dis-
ruption during the ontological peak ofthis
process, which occurs in the second week of
postnatal development in rats and during the
last trimester in humans. However, myelina-
tion continues to progress through adolescence
in both rodents (101) and humans (102-104).
The protracted time course for this process has
I
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also been demonstrated to be vulnerable to
perturbation in both rodents and humans.
Prenatal and postnatal exposure of rats
(105,106), and probablylate prenatal exposure
in humans, to ethanol (107) produces signifi-
cant decreases in myelination and these effects
can persist throughout the postnatal period.
Similar findings have also been observed after
postnatal lead exposure in rats (108-110) and
developmental exposure in humans (111),
where delayed myelination was observed
duringthepostnatal period.
Apoptosis
Proper development ofthe nervous system
requires apoptosis, aform ofprogrammed cell
death that systematically removes large num-
bers ofneurons in some structures produced
during ontogeny. Apoptosis occurs during
both pre- and postnatal development ofthe
CNS in two waves. The earlierwave occurs in
proliferative zones; the second occurs in post-
mitotic cells that are both neuronal and glial
in phenotype (112,113). Apoptosis is distin-
guished from the other general category of
cell death, necrosis, by specific characteristics
including maintenance ofmembrane, chro-
matin condensation, cell shrinkage, oligonu-
cleosomal fragmentation of DNA, and a
general lack of inflammation [reviewed by
Bredesen (114)]. Cells undergoing apoptosis
in the nervous system are targeted asynchro-
nously and removed from the surrounding
tissue without stimulation ofan inflamma-
tory response. In a region sustaining massive
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Figure 8. Proliferation of neurons and glia are depicted with the temporal and regional pattern ofmyelination which
occurs later in development. Abbreviations: A, sciatic nerve; B, whole brain; B1, corpus callosum. The schedule of
brain development for rats and humans is in arbitrary units (x-axis). Adapted from Wiggins (94) and reprinted with
permission of Intox Press, Inc.
developmental apoptosis, only a small per-
centage ofthe cells may be morphologically
identifiable as apoptotic at a given time
(115,116). Thus, characterization ofdevelop-
mental apoptosis may be necessary to under-
stand normal nervous system development
and could elucidate how neurotoxic agents
perturb this process and result in altered cell
number and neural function after exposure
(117,118). This form ofcell death results in
less overt pathology than thatwhich would be
observed after damage to the adult nervous
system but still leads to alterations in cell
number and connectivity within the nervous
system. Anomalous patterns ofthis form of
cell death may be a consequence ofexposure
to environmental neurotoxicants. During crit-
ical periods, exposure to environmental agents
may shift the tightly regulated balance ofneu-
rotrophic signals that regulate apoptosis,
therebycausing alterations that result in unde-
sirable increases or decreases in cell number in
a particular region ofthe nervous system.
Exposure to a number ofagents, including
ethanol (119,120), lead (121,122), methyl
mercury [reviewed by Nagashima (123)], and
chlorpyrifos (33), promotes this process dur-
ing development in rodents. Alterations
induced by xenobiotics can result in the pro-
gressive loss of neurons and may result in
compromised neurological function later in
life, as is the case in some neurodegenerative
diseases (124-128). Although apoptosis has
been studied in neurodegenerative disease,
there has been little work examining the
effects ofenvironmental agents on apoptosis
in thedeveloping nervous system in humans.
Neurotrophic Signals
Cascading events define the entirety ofbrain
development. The number of molecules
involved in modulating neuronogenesis is
enormous. The signal transduction ofthese
trophic molecules uses both second and third
messengers, which may lead to alterations in
gene expression or epigenetic changes via
phosphorylation and/orglycosylation ofexist-
ingsignaling and structural proteins. Changes
in gene expression and signaling are reflected
in cellular processes and events leading to dif-
ferentiation. The intervening factors that can
potentially modulate every step ofa signaling
cascade further complicate investigation of
neuronal differentiation. What follows is a
briefdiscussion ofa few individual molecules
important in proliferation, differentiation,
and apoptosis. Nerve growth factor is the
prototypical neurotrophic ligand. This solu-
ble peptide is a ligand for tyrosine kinase
receptors and p75 receptors throughout the
developing brain. In vivo and in vitro investi-
gations have demonstrated that this ligand
[reviewed by Klein (129) and Zhou and
Bradford (130)] and other structurally
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homologous neurotrophic factors, including
brain-derived neurotrophic factor, neu-
rotrophin-3, and neurotrophin-4, are impor-
tant to many processes in neural development
[reviewed by Barone (131)]. Alterations in the
expression or signaling ofthese trophic mole-
cules result in adverse consequences for both
the structure and function ofthe nervous sys-
tem (131). A number ofstudies have demon-
strated thatchanges in cell excitability resulting
from pharmacological manipulations ofmany
neurotransmitter systems, induding glutamin-
ergic (132-13), cholinergic (138-142), cate-
cholaminergic (143), gabaergic (144), and
peptidergic [opioid agonists and antagonists
(145)] lead to pronounced changes in neu-
rotrophic factor expression. In addition, a
number ofenvironmental chemicals and phar-
maceutical agents alter the expression and/or
signal transduction ofthese trophic molecules,
including ethanol (146-152), methyl mercury
(153,154), aluminum (155), and cholin-
esterase inhibitors (138,139,156). Although
neurotrophic factors are perturbed in experi-
mental animals after exposure to environmen-
tal agents, the involvement ofthese factors in
developmental disorders hasonlyrecently been
suggested inhumans (157).
Neurotransmitters as
Morphogenetic Signals
Neurotransmitters and other ligands have
qualitatively different functions during devel-
opment ofthe nervous system than in the
adult organism. In the adult nervous system
neurotransmitters are classically thought ofas
mediating or modulating synaptic transmis-
sion across a cleft between two cells. However,
during development these same factors may
interact with their cognate receptors over a
much greater distance and form a morpho-
genetic gradient that is important in pattern
formation ofdifferent regions ofthe nervous
system and differentiation ofdifferent neuro-
transmitter systems [reviewed by Buznikov et
al. (158)]. Developmental ontogeny of the
neurotransmitter systems for humans is
detailed in Figure 9 (16). Some factors that are
important for initiating cascades that influence
neural development include the neurotrans-
mitters [reviewed by Cameron et al. (159) and
Chausovsky et al. (160], y-aminobutyric acid
(161,162), excitatory amino acids (163), opi-
oids (164-168), acetylcholine (169) and
acetylcholinesterase (170,171), catecholamin-
ergic agonists and antagonists (172), and sero-
tonin (173). Because many ofthese factors are
pleiotropic and play fundamentally different
roles during development than during adult-
hood (174-176), it would seem prudent to
investigate whether pharmaceutics and pesti-
cides (e.g., insecticides, herbicides, and fungi-
cides) thatare neuroactive ordesigned to target
specific neurotransmitter systems may have
qualitatively different effects than their phar-
macological effects observed in adults. For
example, effects ofthe organochlorine pesti-
cide dieldrin on morphogenesis have been
observed after exposures in whole embryo
culture conditions (177.
It is apparent from the summary ofthese
specific developmental processes that
ontogeny ofdifferent parts ofthe brain occurs
at different times during the prenatal and
postnatal period, thus broadening the tempo-
ral window ofvulnerability and the number
of developmental processes that may be
affected by exposure to xenobiotics. This has
important implications concerning the
anatomical, neurochemical, and functional
consequences ofthe timing ofexposure to a
neurotoxic agent and effects that may be
manifested later in life. For example, short-
term exposure to a neurotoxicant during
week 4 ofgestation in humans (or on GD 11
in rats) would be expected to interfere with
neurogenesis in the spinal cord and hindbrain
structures but not the more anterior structures
ofthe brain. In contrast, toxic insult at theend
ofgestation in humans or in the first postnatal
week in rats might affect neurogenesis in cere-
bellum and hippocampus, as well as possibly
other processes (cell migration, myelination,
and synaptogenesis) in areas that have already
undergone neurogenesis. Specific effects would
depend not only on the timing and duration
ofthe exposure but the processes affected by a
specific neurotoxicant. Numerous neurotoxi-
cants can affect the same developmental
processes depending on dose and duration. In
manycases, these effects on these developmen-
tal processes are mediated through very differ-
ent mechanisms. By inference the effects on
the developmental processes reflect down-
stream convergence on modes ofaction critical
to the normal development and function of
the nervoussystem.
Application of Molecular
Biologyto Developmental
Neurotoxicology
The application ofmolecular techniques and
transgenic technologyhas manyadvantages in
elucidating the mechanistic role ofspecific
molecules to affect the normal development
ofthe nervous system. In manycases antibod-
ies are not readily available for specific pro-
teins that are used as markers of these
developmental processes. In some instances
mRNA levels or in situ hybridization of
mRNAs have been used as surrogate molecu-
lar markers of the proteins important to
developmental processes. Application and
generalization ofresults of mRNA studies
warrant a good degree ofcaution until the
relationship between mRNA levels and pro-
tein levels is well characterized. Recent evi-
dence from studies characterizing the normal
ontogeny ofneurotrophins demonstrates that
it maybe erroneous to assume that expression
ofa specific mRNA is predictive ofthe corre-
sponding protein levels due to posttranscrip-
tional and/or translational regulation (178).
Interestingly, neurotrophin mRNA levels in
one region were not closely correlated with
their corresponding neurotrophin protein lev-
els and consequently not predictive of
regional neurotrophin protein levels (178). In
short, molecular approaches may be useful in
mechanistic studies and in the context of
gene discovery, but unless they are used in
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Figure 9. Comparison of regional timelines in the receptors for classical neurotransmitter is depicted for humans.
Adapted from Herschkowitz et al. (16) and reprinted with permission of HippokratesVerlag GmbH.
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conjunction with an examination of the pro-
tein levels, they may not always prove useful
in predicting an adverse effect.
Another approach worthy of attention is
the use of knockout and transgenic animal
models. These technologies may be useful in
demonstrating the effects of regulation of
specific molecules during development.
Transgenic technologies may also prove useful
in understanding the role ofgenetic polymor-
phism in response variability when molecular
targets are identified. Recent research has iden-
tified genetic polymorphisms in a number of
enzymes that both metabolize and detoxify
xenobiotics, including pesticides (179). A par-
ticularly salient example is the role ofgenetic
polymorphisms for paraoxonase (179,180), an
esterase that detoxifies many organophospho-
rus pesticides. These polymorphisms appear to
play a role in response variability in the degree
ofcholinesterase inhibition. In addition, there
appears to be ontogenic development in both
rodents and humans that may in part play a
role in age-related sensitivity (2). However,
interpretation ofthese molecular approaches
requires caution when extrapolating the results
to developmental toxicology because knockout
technology may result in an all-or-none
response, which may not be relevant to xeno-
biotic exposure. Conversely, the toxicological
exposure may perturb a molecular mechanism
or group of related molecular pathways and
thus be more adverse than knocking out or
altering one gene product duringdevelopment.
Neuronal Plasticity
It is important to recognize that the nervous
system continues to remodel and change not
just early in development but throughout the
entire period ofdevelopment (and even dur-
ing adulthood) in response to environmental
influences as well as genetically programmed
events. One mechanism for this remodeling is
the normal genetically programmed overpro-
duction and subsequent elimination of neu-
rons and neuronal processes. For example,
there has been extensive research on this issue
in the rhesus monkey by Pasko Rakic and col-
leagues (181). Synaptic density in primary
visual cortex increases until approximately the
third postnatal month, then decreases until
about 2 years of age, followed by a slower
decrease between 2.7 and 5 years of age
(puberty) (181). The timeframe ofsynaptic
development in monkey cortex is the same for
areas including somatosensory, motor, and
prefrontal cortex (182), suggesting that cell-
to-cell communication in the neocortex may
be orchestrated by a single genetic or humoral
signal. The overproduction and subsequent
elimination of neurotransmitter receptors in
disparate areas of the monkey neocortex is
synchronized with synaptogenesis (183,184.
In contrast, elimination of neurons in the
lateral geniculate nucleus of the thalamus,
which is up-system from neocortex, occurs
during the middle third ofgestation (185).
These examples demonstrate the elegant and
orderly sequence of elimination of neuronal
elements during development, which contin-
ues at least until puberty. In motor cortex of
the monkey, synaptogenesis continues for sev-
eral months postnatally, and then decreases
until approximately 10 years ofage (well after
puberty) (186). Similarly, synaptogenesis in
prefrontal (66) and somatosensory cortex
(187) continues into the early postnatal period
followed by a slow decline into adulthood.
Approximately 70% of the axons in the cor-
pus callosum are eliminated between birth
and 4 months ofage (188).
Environmental input plays a crucial role
in the development ofthe architecture ofthe
brain after birth. The seminal work ofDavid
Hubel and Torsten Wiesel, for which they
won the Nobel Prize in Physiology and
Medicine in 1981, demonstrated significant
remodeling of the visual system ofkittens in
response to deprivation of input to one eye
(189). The visual cortex was remodeled such
that the primary visual cortex consisted of
representation from only the unoccluded eye.
Further, the kittens appeared essentially
blind in the deprived eye when the lid suture
was reversed at 3 months of age. Similar
results were observed in a series of experi-
ments with monkeys (190). Subsequently,
numerous studies have documented remodel-
ing ofother sensory systems in a number of
species in response to experimental manipu-
lation of input into that system (191-195).
Interestingly, when kittens are deprived of
visual input from birth, an area of the pari-
etal cortex normally associated with vision is
taken over almost completely by auditory
and somatosensory inputs (196). Auditory
neurons in this area exhibited sharper spatial
tuning in visually deprived cats, and these
cats could localize sound sources more
precisely than nondeprived cats.
Other brain areas also respond to early
experience. For example, rearing rodents in
enriched environments compared to impover-
ished or typical laboratory environments
resulted in significant increases in cortical
thickness, dendritic branching, and synaptic
density (197-200). Exposure to enriched
environments early in development also
results in improved performance on learning
tasks in rats (201). The environment during
the first several years of life in humans may
also have profound effects on structure and
function ofthe limbic system (202), which is
critical for social and emotional function.
Neuronal plasticity continues at least
throughout childhood and into adolescence.
Computational analysis of the brains ofchil-
dren 4-17 years ofage revealed an age-related
increase in the size of fiber tracts supporting
motor and speech functions (104) (Figure
10). In an example of remodeling in the
somatosensory cortex in response to experi-
ence, magnetic resonance imaging (MRI)
revealed that the cortical representation ofthe
left but not the right hand ofstring players was
larger than in nonplayers, and that the increase
in area was correlated with the age at which
individuals began to play (203) (Figure 11).
Other researchers have also identified contin-
ued development ofbrain structures through
late childhood, adolescence, and young adult-
hood using imaging techniques (204-206).
Assessment of Nervous
System Function in Animals
and Humans
There are a number ofstandardized clinical
tests for assessment ofthe integrity ofnervous
system function in the developing human
from infancy through the school years.
Standardized test batteries such as the
Neonatal Behavioral Assessment Scale
(NBAS) are available for assessing intactness
ofthe nervous system in young infants, mea-
suring such functions as neuromuscular and
motor reflexes, reaction to sensory stimuli,
habituation to repeated stimuli, and auto-
nomic function (207,208). Assessment of
neurological and cognitive development may
be performed in children by the use of age-
adjusted scales such as the Bayley Scales of
Infant Development in very young children,
the McCarthy Scales of Children's Ability
(MSCA), and the Kaufman Assessment
Battery for Children in older children. These
instruments include tests for psychomotor,
memory, verbal, perceptual, and other com-
ponents depending on the instrument and age
range being assessed. In older children, the
Weschler Intelligence Scales for Children -
Revised (WISC-R) is typically used to assess
cognitive function; this instrument is divided
into a number of subscales to partition out
various aspects of cognitive performance.
Performance on early childhood tests is not
predictive ofperformance on the WISC-R at
school age for the general population ofchil-
dren (209) but may have better predictive
power for low-functioning children (210).
There has also been some research on the
development ofplay behavior in young chil-
dren (211-214), including the correlation
between play and language development
(215) and coping behavior (216). A test that
has proved extremely useful in the assessment
of the cognitive abilities of infants is the
preferential-looking test [Fagan test (217)].
This test takes advantage of the fact that an
infant looks longer at a novel stimulus (e.g., a
picture ofa face) than at a familiar one, and so
the test can be used to assess short-term mem-
ory. If the infant looks longer at the novel
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stimulus than at the one previously presented
(preferential looking), it is assumed that the
infant remembers the previously presented
stimulus. This task is more highly correlated
with later performance on intelligence quo-
tient (IQ) tests than sensorimotor tests such as
the Bayley Scales (218). Preterm infants do
less well on tests ofpreferential looking at 6
and 12 months ofage than full-term infants
(219), a finding that has been replicated in
infant monkeys tested at corresponding ages
(220). Monkeys exposed to methyl mercury
in uteroperform more poorly on this task than
do control monkeys (221), as do human
infants exposed prenatally to PCBs (222).
There are other cognitive behaviors that
may be tested in very young infants, such as
imitation offacial expressions (223), a form
ofcross-modal matching (i.e., visual and sen-
sorimotor). Young infants are capable of
cross-modal matching in other modalities as
well, such as visual tactile (224). Infants
also progress through a series of stages of
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understanding that an object that is no longer
in sight still exists (225), a cognitive awareness
labeled object permanence. A comparison of
tests ofearly cognitive function and later IQ
(224) revealed agood correlation between pref-
erential looking, cross-modal matching, and
object permanence with IQ at 6 years ofage.
Additionally, results ofpreferential-looking
tests at 7 months of age and cross-modal
matching tests at 1 year ofage predicted chil-
dren considered to be at risk for learning dis-
abilities at 6 years of age. Development of
object permanence is also retarded in infant
monkeys exposed prenatally to methyl mer-
cury (226). An assessment ofconcurrent pre-
dictors ofIQ in children 6 years ofage (227)
found ahigh correlation between IQand tasks
that may be performed in animals, including
delayed match to sample (DMTS) and condi-
tional discrimination. Another test that is
highly correlated with IQ is speed ofinforma-
tion processing, including complex reaction
time (228-231). This test has been used in
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monkeys to assess cognitive effects ofdevelop-
mental methyl mercuryexposure (232).
Tests ofsensory function, motor function,
reflex ontogeny, and learning have been incor-
porated into a number ofbehavioral teratol-
ogy rodent screening batteries like the
Cincinnati Psychoteratogenicity Screening
Test Battery (233), Barlow and Sullivan
Screening Battery (233), and the U.S.
Environmental Protection Agency testing
guidelines for developmental neurotoxicity
(234). These screening batteries were designed
with considerable emphasis on apical tests of
function during development. Specific tests
have been developed to assess the ontogeny of
sensorimotor function in the rat, including
habituation, reactivity, exploratory behavior,
and motor coordination and integrity
(235-238). Such tests assess many ofthe same
functions as the NBAS and Bayley Scales used
with human infants and toddlers. Other early
tests of nervous system integrity in rodents
may include homing behavior (returning to
the nest or siblings), cliffavoidance, placing
reaction, passive avoidance, and escape latency
on a swimming task. Whereas most ofthese
behaviors show a smooth pattern ofdevelop-
ment some time during the first 21 days oflife
(236) (e.g., Figure 12), the ontogeny ofmotor
activity and exploration activity displays a
more complicated pattern (235) (Figure 13).
Locomotor activity increases and then
decreases during the first 21 days oflife, and
then increases again after weaning. The
decrease in locomotor activity is mirrored by
an increase in exploratory behavior during
that developmental period. The emergence of
locomotor behavior reflects the development
of mesencephalic and spinal function, from
crawling at PND 10 to an adultlike pattern at
PND 15 in rats (235). Similarly, the increase
and later decrease in exploratory activity is
presumed to be reflective ofthe brain circuits
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Figure 10. Postnatal myelination in humans, with increasing white matter density for the internal capsule and arcu-
ate fascicularus for 111 children and adolescents ranging in age from 4 to 17 years of age. The internal capsule is a
fiber tract involved in motor function; the left arcuate fascicularus subserves speech function. The late maturation of
these pathways suggest ongoing increases in diameter and/or myelination of axons at least through adolescence.
Adapted from Paus etal. (104).
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Figure 11. Center of cortical responsivity for tactile
stimulation to the fifth (little) finger of the left hand in
string players and controls, as measured by MRI. String
players had an expansion of the cortical area devoted to
the hand area thatwas correlated with the age at incep-
tion of musical practice but not the amount of practice.
Adapted from Elbert et al. (203).
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"coming online" for attention to and integra-
tion ofsensory information, followed by the
ability to cease to attend to irrelevant stimuli.
The ontogeny ofspecific tasks that rely on
hippocampal function and integration with
other neural circuits has also been a specific
focus for research in the rat (Table 1) (2391.
A number oftasks may be used in both
animals and humans to assess cognitive func-
tion. Although some ofthese are used mostly
with monkeys, a number ofthem can also be
used with rodents. Simple visual discrimina-
tion tasks, in which the subject must learn
which oftwo stimuli is correct, can be used
with many species. An additional requirement
that is often imposed is termed discrimination
reversal. After the subject learns the task to
some predetermined criterion, the positive
Righting on surface j
Negative geotaxis (150 incline)
Negative geotaxis (25° incline)
Pivoting
Orientation with pivoting [
Cliff avoidance
Placing (vibrissae elicited)
Placing (chin elicited)
Elevation ofshoulder
Homing (on level surface) L 2
Elevation of head
Quadruped balancing (hind limb)
Ascending onwire mesh
Head pointing (rough surface)
Head pointing (smooth surface)
Hind limb support(suspended)
Ascending on ladder
Traversing 3-cm path
Righting in midair
Traversing 12-cm path
Descending onwire mesh
Ascending on rope
Ascending on rod
Descending on ladder
Rearing (withoutsupport)
Descending on rope (head down)
Jumping (across cliff)
(correct) stimulus becomes the negative one,
and vice versa. This requirement is often more
sensitive to disruption by exposure to a toxi-
cant than is the initial acquisition ofthe dis-
crimination task. Developmental lead exposure
produces impaired performance on discrimina-
tion reversal tasks in rats (240), monkeys
(241), and children (242). Another task that
has proved sensitive to developmental neuro-
toxicant exposure is the delayed alternation
task, in which the subject is required to simply
alternate responses between two positions on
successive trials to be reinforced. Delays
between opportunities to respond may be
imposed to assess short-term spatial memory.
Performance on this task has proved sensitive
to developmental lead exposure in rats (243)
and monkeys (244,245). Developmental PCB
exposure also produces impaired performance
in both species (246,24X.
The delayed response (DR) task used with
monkeys and infant humans is avariant ofthe
delayed alternation task. In this task, the sub-
ject watches one oftwo positions being baited
(with food or a preferred toy, for example)
and then a delay is interposed during which
the subject is prevented from viewing the
stimuli. After the delay, a correct response
(reach) results in attainment ofthe reward. As
long as the subject's responses are correct, the
correct stimulus alternates between two possi-
ble positions from trial to trial. In the typical
DR task, the correct position continues to
alternate irrespective ofwhether a particular
response is correct. Thus, a subject could
always respond at one position, left or right,
and be correct 50% ofthe time. In an alterna-
tive version ofthe task, incorrect responses are
"corrected"; i.e., the correct position remains
on the same side until the subject responds on
that side. This task has been much studied in
human infants, and is referred to as A not B.
Delayed alternation can also be tested as a
corrected or noncorrected task.
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Figure 12. Summary diagram of the emergence of different postural, locomotor, and other related skills in rats. In the
majority of instances performances levels 125, 50, 75, and 100 percent) refers to the percentage of rats successful in
the display of the response. In a few instances the reference is to a level of performance with respect to asymptotic
responsefrequency. Redrawn from Altman and Sudarshan (236) and reprinted with permission of Academic Press, Ltd.
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Figure 13. Ontogeny of motor activity and exploratory
behavior in rats. Locomotion was measured by crossing
of photocell beams in an area 36 x 36 cm. Exploration
was measured by number of nose pokes into holes in
the floor ofthe same apparatus. Activity patterns display
a complex ontogenetic development, with exploratory
and locomotor activity being more or less inversely
related. Adapted from Bi and Seri (235) and reprinted
with permission of Elsevier Science Ltd.
Table 1. Timetable of hippocampally mediated
functions in rats.
Emergence of
adult levels of
Behavioral tasks proficiency on PND
Partial reinforcement inhibition 12-14
Olfactory reversal 18
Morris water maze 21-23
Delayed alternation 21-27
Spatial navigation 22-25
Pavlovian trace fear conditioning 25
Habituation to novel stimuli 25-30
Passive avoidance 25-30
Spontaneous alternation 27-30
Latent inhibition 32
Adapted from Bachevalier and Beauregard (239.
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Tasks that have been used extensively in
monkeys are DMTS and delayed nonmatch-
ing to sample (DNMTS). These tasks are also
suitable for use with rats and have been used
to study the ontogeny of specific brain
regions in human infants. In the DMTS, the
subject is presented with a stimulus, which is
then withdrawn. After a delay, which may
vary from trial to trial, the subject is pre-
sented with the previous stimulus plus one or
more additional stimuli and must choose
(match) the previously presented stimulus. In
the DNMTS, the subject must choose the
novel (nonmatch) stimulus from a pair of
stimuli. The DNMTS is typically easier to
learn because test subjects prefer a novel to a
familiar stimulus. This task has been used in
both children (227) and monkeys [reviewed
by Webster et al. (248) and Murray and
Mishkin (249)]. The DMTS task has proved
sensitive to disruption by developmental lead
exposure in monkeys (250).
Intermittent schedules of reinforcement
have been used extensively in behavioral
pharmacology and toxicology to assess the
effects ofenvironmental agents on behavioral
function (251). On an intermittent schedule
of reinforcement, the subject is reinforced
according to a set ofrules: for example, after
emitting a certain number ofresponses (fixed
ratio), or for the first response after a specified
period of time that remains constant from
one reinforcement opportunity to the next
[fixed interval (F1)]. Although only one
response at the end ofthe interval is required
for reinforcement, Fl performance is typically
characterized by a gradually accelerating rate
of response terminating in reinforcement;
both the temporal pattern ofresponding and
the rate of response may be modified by
exposure to a toxicant. The Fl schedule has
proved particularly sensitive to developmental
exposure to such agents as lead, PCBs, methyl
mercury, and pesticides in both rats and
monkeys (252-260). Performance on other
intermittent schedules has also proved sensi-
tive to disruption by developmental toxicant
exposure (261).
An issue that is of particular importance
in the design ofanimal behavioral studies is
whether each task is assessed independently in
experimentally naive animals or whether a
series oftasks is presented sequentially to the
same subjects. Children are ofcourse required
to build knowledge and skills sequentially,
necessitating transfer oflearning in virtually
all aspects oflife. In contrast, many develop-
mental toxicology studies oflearned behavior
in rodents use a separate set ofsubjects for
each task or the same set of animals for at
most a couple of tasks. Primate research, in
contrast, necessitates testing the same cohort
ofsubjects on many tasks to maximally utilize
an expensive and valuable resource. Whether
failure to assess cumulative learning misses an
important aspect ofchildhood experience is
an important question. In a direct com-
parison using a rat model of maternal
phenylketonuria, it was determined that the
requirement for cumulative learning on a
series of related tasks revealed treatment-
related deficits that were absent when each
task was assessed in a naive group ofanimals
(262). This is consistent with the finding that
one ofthe characteristics ofhumans with low
IQs is an impairment in the ability to transfer
learning from one situation to another (263).
Therefore, low performance on an IQ test
may be viewed as reflecting an accumulated
deficit as a result ofyears offailure to transfer
and integrate previous experiences. This issue
is also relevant to the findings from longitudi-
nal prospective studies assessing the behav-
ioral consequences ofdevelopmental exposure
to toxicants. For example, the apparent cog-
nitive decrement produced by lead may
become more apparent as the child gets older
[reviewed by Rice (264)]. Similarly, cognitive
impairment was not identified at 18 months
ofage in a cohort ofchildren exposed in utero
to PCBs (265) but was manifest at 42 months
in the same cohort (266). Some ofthe appar-
ent increased sensitivity undoubtedly results
from the more informative assessments possi-
ble as the child develops; however, an inabil-
ity to build on previous learning may also
play a part.
Assessment of sensory system function
may be performed in much the same manner
in humans and experimental animals. Sensory-
evoked potentials can be measured easily in
both rats and humans, as well as other
species. Exposure to environmental agents
may produce similar effects on visual-evoked
potentials in pigmented rats and humans
(267). Changes in auditory-evoked potentials
have been demonstrated in different popula-
tions ofchildren as a result ofdevelopmental
exposure to methyl mercury (268,269) or
lead (270). The reflex modification auditory
procedure relies on the fact that an animal
will startle (jump or flinch) when presented
with an intense stimulus, and that this effect
is attenuated ifa stimulus detectable to the
animal is presented approximately 100 msec
beforehand. This procedure can therefore be
used to determine sensory thresholds. This
paradigm revealed that exposure to PCBs
produces low-frequency hearing deficits in
rats (271) during the early postnatal period of
cochlear development. Psychophysical assess-
ment, in which the subject is "asked" to indi-
cate whether or which stimulus is detectable,
is appropriate for humans and other animals.
Such procedures have been used to assess
function in visual, auditory, or somatosensory
systems in rats, monkeys, and humans after
toxicant exposure (244,272-275).
Neurobiological Substrates
of Function
All of the major brain structures in humans
are also present in rodents and subserve
roughly the same functions. The brain stem is
mostly responsible for autonomic functions,
arousal, and sleep-wake cycles. Some mesen-
cephalic structures may also be involved in
cognitive processes in addition to attentional
ones (276,277). The cerebellum subserves
motor function and motor learning (278); its
role in cognitive processes has only recently
been characterized (279,280). Specific areas
of the basal forebrain are involved in motor
function as well as some types oflearning.
It must be borne in mind that all brain
areas have multiple reciprocal connections,
forming circuits subserving various functions.
For example, sensory association areas are
connected to other areas of neocortex respon-
sible for higher order cognitive function.
Cortical and subcortical motor areas form
numerous connections, and also form circuits
with prefrontal cortical and sensory areas. It is
generally believed that there are at least two
different forms of memory processes, based
on studies in monkeys and humans with
amnesia resulting from damage to specific
brain areas. These are labeled variously by dif-
ferent authors and include habit versus non-
habit, procedural versus declarative, and
reference versus working memory (the last
typically by investigators working with
rodents). Habit is generally believed to be
subserved by a corticostriatal circuit (which
seems to be present very early in infancy),
whereas nonhabit memory is subserved by a
corticolimbic circuit [which develops later in
infancy (239)]. Damage to a particular struc-
ture in the circuit or a connecting pathway
may produce structural or functional changes
upstream or downstream and result in behav-
ioral changes that are a consequence of
damage to the circuit as a whole.
It is clear that the basal forebrain is
involved in habit formation (281): i.e., proce-
dural memory that does not require holding
information temporarily "online," such as
discrimination tasks or motor skills. It has
recently been argued that the basal forebrain
is involved in both habitual and nonhabitual
responses (282,283). Lesions ofvarious areas
of basal forebrain produce deficits in perfor-
mance on nonhabit tasks such as delayed
alternation and DNMTS as well as on habit
tasks such as discrimination reversal and other
discrimination tasks.
The limbic system consists of medial
temporal lobe structures including hippocam-
pus, amygdala, and surrounding cortical
structures. Researchers using the rodent as the
experimental subject have probably studied
the function of the hippocampus more than
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any other brain structure involved in learning
and memory, perhaps because the hippocam-
pus in the rodent is relatively large and easy
to identify cytoarchitectonically. The hip-
pocampus is involved in spatial memory in
both rodents and primates and is also critical
for very short-term memory storage, at least
in monkeys (284). It is unclear whether the
deficits observed on such nonhabit tasks as
delayed alternation (DA), DR, and DNMTS
are the result oflesions ofonlythe hippocam-
pus, the hippocampus plus amygdala, and/or
the surrounding entorhinal and perirhinal
cortex (281,285-288).
The neocortex is divided into areas sub-
serving anumber offunctions in both rats and
primates, including humans [Figure 14,
(289,290)]. Specific areas are devoted to
motor function and the various sensory sys-
tems, including visual, auditory, and various
somatosensory modalities. These functional
areas are further subdivided into primary cor-
tex, which receives input directly from the
corresponding thalamic nucleus, and various
areas upstream that are responsible forintegra-
tion and higher order processing. This expla-
nation is a simplification: there is some
thalamic input to nonprimary sensory cortex
as well, but the bulk ofthalamic input is to
primary cortical areas. Perhaps the biggest dif-
ference between rodents and primates (indud-
ing humans) in terms of sensory system
structure andfunction is the fact that primates
are highly visual animals, whereas the rodent
relies heavily on auditory and olfactory cues
(as well as tactile cues from the vibrissae) for
information about the world. Consequently,
approximately halfofthe primate brain is
devoted to visual areas, induding higher order
processing and integration areas. In contrast,
onlyasmall partofrodent cortex isdevoted to
vision. The visual function ofprimates is also
more highly developed than that of the
rodent, with excellent color discrimination
andspatial resolution, ofwhich the rodenthas
neither [Figure 15 (291)]. The rodent there-
fore has considerable limitations with respect
to utility for the assessment ofvisual function,
although there are certain aspects ofvisual
structure and function shared between the
species (e.g., low-light-sensitive rod-mediated
visual pathways). The presumed relative
unimportance ofvisual information compared
to information from other sensory modalities
in rodents also has implications for testing
paradigms: the stimuli used for assessing cog-
nitive function in rodents are typically visual
stimuli, probably in part because they are easy
to control and in part because we are visual
animals. Itwould seem preferable to use olfac-
tory cues when assessing cognitive abilities in
rodents (262). It should also be emphasized
that both the visual and auditory systems of
albino animals ofall species are abnormal
(e.g., Figure 15); therefore, albino rats or mice
are a poor choice for assessment when the
nervous system is ofinterest.
Undoubtedly, the most obvious and
important difference between the rodent and
human brain, structurally and functionally, is
the tremendous relative size and functional
importance ofthe prefrontal cortex (PFC) in
humans. Homologous areas ofPFC between
species are typically defined by projections
from specific thalamic nuclei. Bythatcriterion,
the rat has a defined PFC that may be subdi-
vided into a number ofareas (292). The pri-
mate cortex, including that ofthe human, is
also dividedstructurallyandfunctionallyinto a
number ofspecific areas (293,294). The PFC
in primates is considered necessary for so-
called executive functions (283,295,296),
induding organization ofbehavior in time and
space, planning, inhibition ofinappropriate
actions (impulse control), ability to change
strategy (set-shift), and emotional control. It
has been suggested thatattention deficit hyper-
activity disorder is largelya dysfunction ofpre-
frontal cortical function (297). It has also been
postulated that damage to prefrontal cortical
areas underlies the behavioral impairment pro-
duced by developmental lead exposure (298).
Lesions ofvarious specific areas ofPFC in
monkeys produce deficits in DA and DR,
DMTS and DNMTS, and discrimination
tasks. Such lesions also result in impairment in
A Somatosensory Motor cortex
cortex Visual
I f P^nrtEx
B Motorcortex Somatosensory cortex
bulb / f /
Expressive Auditory Receptive Primary
speech cortex speech visual
area area cortex
(broca)
Figure 14. Lateral view of functional areas of the
(A) rodent and (B) human cerebral cortex. The lateral
view of the rodent neocortex is redrawn from Kolb and
Tees (289) and the lateral view of the human neocortex
is redrawn from Heimer(290). Reprinted with permission
ofSpringer-Verlag.
the ability to inhibit inappropriate respond-
ing, perseveration, and distractibility. At least
some ofthese same functions (e.g., inappro-
priate responding and perseveration) are
impaired after PFC lesions in rats (299).
However, behavioral toxicologists using rats as
the experimental model have generally not
focused on PFC as a possible site oftoxicant-
induceddamage.
An approach that has proved extremely
fruitful in the study ofthe development of
cognitive processes and the brain structures
subserving these processes in human infants is
the assessment of infants on tests used in
adult and infant monkeys, and for which the
brain structures and circuits necessary for per-
formance of the specific tasks have been
delineated. One brain area that has received a
considerable amount ofattentionwith respect
to ontogenetic development is the PFC.
Lesion studies in monkeys have identified a
number oftasks that are heavily dependent
on various areas ofprefrontal cortex, includ-
ing DR, A not B, DA, and DMTS and
DNMTS (300-302). Both infant humans
and infant monkeys develop the ability to
perform these tasks relatively late: over the
course of the first year oflife in monkeys
(303,304) and over the first 3 years or so in
humans (305,306), thereby suggesting a rela-
tively long maturation time for prefrontal
cortex. In fact, development of PFC may
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Figure 15. Comparison of spatial visual function in
various species. Abscissa: spatial frequency. Ordinate:
contrast sensitivity = reciprocal of contrast, which is a
function ofthe difference between the lightand dark bars
of a series of parallel bars. The visual function of the
albino rat is least like thatofhumans(notethree scales of
the ordinate), whereas the contrast sensitivity of many
nonhuman primates are virtually identical to humans.
Adapted from Uhirich et al. (291) and reprinted with
permission ofThe MIT Press and Elsevier Science B.V.
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continue beyond puberty in both species. In
contrast to performance on tasks dependent
on PFC, habit formation tasks such as dis-
crimination tasks, which are dependent on
corticostriatal circuits, are performed at adult
levels of competence in both monkeys and
humans during earlyinfancy (304,307,308).
Another brain circuit for which ontogeny
has been studied is the limbic system, includ-
ing hippocampus, amygdala, and surrounding
entorhinal and perirhinal cortex. The hip-
pocampus develops perinatally in the rat but
prenatally in humans or monkeys during the
last trimester. For example, 15% ofcells in the
dentate gyrus of a rat are present by birth,
compared to 80% ofthe cells present in the
monkey atbirth (308). In humans, thevolume
of the hippocampus is fully mature at 15
months, whereas the PFC does not reach adult
volume until 10 years of age. Preferential-
looking performance is developed at 4 months
of age in humans and 2 weeks of age in mon-
keys (307,308). Lesions ofthe hippocampus
result in impaired performance on this task,
evidence that this structure matures early in
primates (309). Lesions ofhippocampus in
young monkeys also result in deficient social
interactions early in life, which become more
severe during adulthood (310). There is evi-
dence ofdifferences between the sexes in the
development of different brain areas as
revealed bydifferential performance on specific
behavior tasks in young monkeys (311-313)
andhumans (312) that are not present later.
Clinical Consequences of
Errors in Developmental
Processes
It is well established that being small for
gestational age (SGA) is a risk factor for behav-
ioral and other health problems. For example,
in a prospective cohort study of 1,037 chil-
dren, SGA children scored lower on tests of
intelligence when tested repeatedly between 3
and 13 years of age (314,315). Parents
reported more behavioral problems at 15
years of age in the SGA group (315). Being
SGA presumably results from a suboptimum
prenatal environment, and may be an indica-
tion of poor overall nutrition, specific nutri-
tional deficiencies, or other factors including
exposure to a toxicant. Neurotoxic agents
including alcohol, maternal cigarette smok-
ing, PCBs, and perhaps lead all may produce
intrauterine growth retardation. It has been
argued, at least with respect to lead, that con-
trolling this factor in the statistical analysis
represents over-controlling. Prematurity may
also produce retarded development. In a
study following a group ofchildren from
birth to 5 years of age (316), premature
infants initially lagged behind full-term
infants on age-appropriate measures includ-
ing the Bayley Scales, Stanford-Binet, and
MSCA, even when results were age-corrected.
By 5 years of age, the premature infants had
caught up on most, but not all, measures.
Functional abnormalities ofthe nervous
system and their underlying structural and
neurochemical abnormalities may provide
important information relevant to normal
development, as well as perturbations that
may be produced by neurotoxic agents.
Schizophrenia is a devastating mental illness
that probably has both genetic and environ-
mental causes. Although the identical twin of
a person with schizophrenia has a greatly
increased risk ofdeveloping the disease, the
risk has an odds ratio < 1.0, indicating that
environmental influences also play a part in
the etiology. For example, obstetric complica-
tions or maternal influenza during pregnancy
are associated with an increased riskofschizo-
phrenia (317-319).
There is compelling evidence that schizo-
phrenia is a consequence of errors in develop-
mental processes (320) based on the types of
abnormalities observed. Many major psy-
choses, including schizophrenia, become man-
ifest at the end ofadolescence and in early
adulthood. The period ofadolescence is a
time ofhigh synaptic density in all higher pri-
mates, including humans (321) (Figure 16).
Thereafter synaptic density decreases in all
areas of cortex. Recent studies using MRI
(322) suggest excessive elimination ofden-
drites and axons ofprefrontal cortex ofschizo-
phrenics. Consistent with these results are the
findings ofreduced neuropil and increased
density of neurons per unit volume compared
to controls in PFC (323) and other brain areas
ofschizophrenics (324). Significant volume
loss has also been reported in temporal cortex
(325) and frontal lobe ofschizophrenics (326),
as well as a greater increase in ventricular vol-
ume during adolescence in schizophrenics
compared to controls (327).
It has been argued that schizophrenia is
fundamentally a deficit in working memory,
and that the disorganized thought processes in
schizophrenia patients result from an inability
to accurately retrieve symbolic representation
fromlong-term memoryand hold it "in mind"
for use in the absence ofexternal cues (328).
Various areas ofPFC are intimately involved
in this type of information processing.
Research with noninvasive methods including
positron emission tomography scanning and
functional MRI revealed abnormalities in
function in PFC ofschizophrenics performing
working memorytasks (320), induding abnor-
malities in dopaminergic function (329).
Alternatively, it has been argued that abnor-
malities ofmedial temporal lobe, particularly
hippocampus, are intimately involved in the
pathogenesis ofschizophrenia (330).
Dyslexia is another mental disability in
which specific abnormalities ofdevelopment
are observed. Dyslexia is associated with neu-
ronal ectopias and architectonic dysplasias in
various areas ofthe cerebral cortex (331,332)
as well as other structural abnormalities. In
addition, people with dyslexia have a lack of
asymmetry in the planum temporale, a lan-
guage region on the superior surface ofthe
temporal lobe that is asymmetrical in
nondyslexic individuals (331). Dyslexics are
also more likely to have autoimmune disor-
ders and an increased incidence ofleft-hand-
edness (333). Autoimmune strains ofmice
have been developed that also have cerebral
ectopias and aberrant cortical lateralization
(334,335), which are ofgenetic origin. These
mice also show differences in various tests of
spatial learning, which may be modified by
environmental enrichment (336).
Epilepsy is a nervous system abnormality
that in some cases has a developmental etiol-
ogy. A large program studying the causes of
epilepsy has been ongoing in Rochester,
Minnesota, since 1975 (337). From that large
database it is estimated that approximately 5%
ofepilepsies have a developmental origin.
One-third ofchildrenwith severe mental retar-
dation or cerebral palsy (CP) also have
epilepsy. Perinatal events such as repeated or
prolonged febrile seizures may result in
epilepsy, and there is evidence for genetic
causes forepilepsyin some families. CP is asso-
ciated with abnormalities ofpregnancy and
birth, particularly birth asphyxia and low birth
weight (prematurity) (338). Cranial ultrasound
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Figure 16. Developmental ontogeny of synaptic density
for monkey (top) and human primary visual cortex (area
17 or striate cortex) or prefrontal cortex (area 46 in mon-
keys). Abbreviations: B, birth; P, puberty. Data in the bot-
tom panel are normalized as a percentage ofthe maximal
value of the curve. Adapted from Rakic et al. (321) and
reprinted with permission of ElsevierScience B.V.
Environmental Health Perspectives * Vol 108, Supplement 3 * June 2000
1
, ..
524CRITICAL PERIODS FOR THE DEVELOPING NERVOUS SYSTEM
imaging in preterm infants may reveal patterns
ofneonatal brain damage that are highly pre-
dictive oflater CP: specifically, echodense
regions that presumably reflect ischemic or
infarctive lesions ofthe white matter. CP may
in some instances result from disorders ofneu-
ronal migration (339,340) or periventricular
white matter damage that may arise during
weeks 28-35 ofgestation (339,340).
Autism is a developmental abnormality
that is characterized by impairment ofsocial
interaction, limited activities or interests, and
deficiency or abnormality ofspeech develop-
ment. Autism occurs with a prevalence of 1.3
per 1,000 births (341). Although there is a
strong genetic factor in autism, it is not herita-
ble in a simple fashion, and environmental
factors also play a role. In an insightful piece
of detective work, Stromland et al. (342)
observed that in the Swedish thalidomide reg-
istry, there were several patients with autism
who had all been exposed to thalidomide
between GD 20 and 24. This time period cor-
responds with closure ofthe neural tube and
production ofthe first neurons that form the
motor nuclei ofthe cranial nerves. Moreover,
these individuals also had ear malformations
and hearing deficits, providing further evi-
dence for damage in this shortwindow during
gestation. Rodier et al. (343) reproduced the
major features ofthe neuropathological syn-
drome ofautism using valproic acid in mice
because mice are not sensitive to thalidomide-
induced teratogenicity. These abnormalities
are also observed in mice inwhich the hox-AJ
gene is lacking (344-346). The hox-AJ gene is
present in humans (347), although the conse-
quences ofalterations in expression and/or sig-
naling through either genetic mutations or
exposure to environmental agents is an area in
need offurther research.
Long-Latency Delayed
Neurotoxicity
An issue that is ofconsiderable concern to
neurotoxicologists, and which has great rele-
vance to risk assessment, is the potential for
agents to induce delayed neurotoxicity years
after cessation ofexposure, including expo-
sure during development. The possibility of
delayed neurotoxicity stems from at least two
scenarios. In one scenario, the ontogeny ofa
particular function occurs late in develop-
ment and the manifestation ofpathological
changes is not revealed until the function in
normal animals is apparent. A second sce-
nario involves a developmental insult in
which both anatomical and/or functional
effects may be masked or attenuated due to
neuronal compensation or plasticity, resulting
in apparently transient effects that may
nonetheless have later sequelae. The possibil-
ity ofan interaction between aging and expo-
sure to neurotoxic agents is also ofcritical
concern: this possibility was postulated 2
decades ago (348) and has been raised repeat-
edly since (349,350). As the normal brain
ages, there is a decrease in the number ofcells
in certain regions, as well as a decline in neu-
rotransmitter levels and repair mechanisms. If
this process were accelerated by chronic or
historic exposure to a neurotoxicant, the
effect as the individual aged would be a fur-
ther decrease in functional capacity from that
typically observed during aging. Alternatively,
damage that decreased the reserve capacity of
the brain at any point in life might also
hasten the appearance offunctional deficits.
This phenomenon has been demonstrated
in both animal models and in humans. In
rodents, latent neurotoxicity has been
demonstrated after developmental exposure
to X-ray irradiation (351), methyl mercury
(352), and triethyltin (73). Developmental
exposure to triethyltin produced damage to
cortical structures ofthe nervous system and
transient deficits in spatial learning. Apparent
compensation at the anatomical level was evi-
dent, with some reactive synaptogenesis from
surviving cells in the entorhinal cortex and a
recovery from spatial learning deficits during
adulthood. However, when littermates were
examined morphologically and functionally
during aging, decreases in synaptic densities
and deficits in spatial learning became appar-
ent, providing empirical evidence for acceler-
ated aging as a result of developmental
exposure (73).
There is both epidemiological and experi-
mental evidence that exposure to the environ-
mental contaminant methyl mercury can
produce delayed neurotoxicity (353). Methyl
mercury toxicity is largely characterized by
abnormalities in motor function and impair-
ment in the visual, auditory, and somatosen-
sory systems. As early as 1975 it was
recognized that manifestations ofMinamata
disease (MD) could worsen over time even
after cessation ofexposure to methyl mercury
(354,355). Astudy in Japan induding > 90%
of persons diagnosed with MD and age-
matched controls identified deficits in the abil-
ity ofpersons with MD to independently eat,
bathe, use the toilet, dress, andwash their faces
(356). The relative deficit between controls
and people with MD increased with age in a
statistically significant manner even though
exposure to methyl mercury had ceased in all
individuals 20-30years before assessment.
Delayed neurotoxicity has also been
observed in monkeys exposed developmen-
tally to methyl mercury. Monkeys exposed to
methyl mercury from birth to early adult-
hood developed clumsiness beginning in mid-
dle age (357), which was probably a
consequence ofsomatosensory dysfunction
(358). This cohort ofmonkeys, as well as a
cohort exposed to methyl mercury in utero
through puberty, developed deficits in fine
motor control during middle age (353). The
group ofmonkeys exposed in utero through
puberty displayed exacerbation ofauditory
impairment as theyaged (359). Individuals in
both cohorts developed constriction ofvisual
fields during old age that had not been pre-
sentwhen theywereyounger (360).
An interaction between aging and neuro-
logical disease during childhood has also been
observed. It has become apparent over the last
decade that up to 25% ofpeople who had
contracted polio as children had apparently
recovered and were functioning normally,
then suffered a recurrence ofclinical symp-
toms as theymoved into middle age. Evidence
ofdegeneration in peripheral nerves ofthese
individuals was detected; this may reflect pre-
mature senescence of nerves compromised
during the acute phase ofthedisease, or accel-
erated aging produced by increased metabolic
demands on spared normal nerves. Exposure
to the polio virus during childhood may also
result in the development ofmotor neuron
diseasedecades later (361).
The potential consequences ofan interac-
tion ofdevelopmental exposure to aneurotoxic
agent and acceleration ofthe aging process are
profound. As the large cohortofbabyboomers
ages, the costs ofneurological or psychological
dysfunction will be significant, and any added
increase in dysfunction as a consequence of
exposure to neurotoxic agents maybe expected
to place additional burdens on the cost and
infrastructure ofthehealth caresystem.
Antisocial Behavior Associated
with Early Neurotoxic
Exposure
Another form oflatent consequences after
developmental exposure to neurotoxic agents
is exemplified by magnification ofearly
deficits with maturation to adulthood. There
is increasing evidence linking aggressive
and criminal behavior with decreased IQ
(362,363) as well as with other deficits typical
ofexposure to neurotoxicants, such as impul-
sivityandpoorexecutive control. In astudyof
aggressive and nonaggressive adolescent boys,
the best predictor ofaggressive behavior was
deficits in executive function (364). Children
diagnosed with hyperactivity disorders have
increased incidence ofdepression and aggres-
sion at 17-18 years ofage (365), whereas indi-
viduals with various psychiatric disorders are
at increased risk for criminal behavior (366).
There is also increasingly compelling evidence
for an association between aggressive behavior
duringchildhood and later increased criminal-
ity in males, but not females, as a result of
developmental exposure to neurotoxicants.
Determination of such long-term effects
requires long-term follow-up ofcohorts in
which exposure during development was
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determined. Three toxicants have been stud-
ied long enough to perform such assessments:
lead, alcohol, and cigarettes. Exposure result-
ing in an increased body burden oflead was
largely postnatal, whereas maternal alcohol
consumption or cigarette smoking resulted in
prenatal exposure to the fetus. All three agents
produce deficits in IQ, attention problems,
increased impulsivity, and deficits ofexecutive
function. All three are also associated with
increased criminality during adulthood as a
resultofdevelopmental exposure.
Consequences of
Developmental Lead Exposure
An association between leadexposure andanti-
social and other problem behaviors has been
identified in children as young as 2-5 years of
age (367,368). In astudy in children 8 years of
age, tooth dentine lead levels were associated
with total scores ofproblem behavior on the
Teachers Report Form ofthe Child Behavior
Profile (369). Tooth lead levels were also asso-
ciated with internalizing (consisting ofscores
for anxiety or withdrawal) and externalizing
(consisting ofinattentive, nervous-overactive,
and aggressive scores). There was also a weak
association between tooth lead levels and
prevalenceofextreme problembehavior scores.
The consequences in older children ofthis
poor social adjustment were explored in a ret-
rospective cohort study ofthe association
between bone lead levels and measures of
social adjustment in boys at 7 and again at 11
years ofage (370). At7years ofage, borderline
associations after adjusting for covariates were
observed between teachers' ratings and lead
levels for aggression, delinquency, social prob-
lems, and externalizing behaviors on the Child
Behavior Checklist (CBCL). When these chil-
dren were 11 years ofage, parents ofsubjects
with higher lead levels reported significantly
more somatic complaints, more delinquent
and aggressive behavior, and higher internaliz-
ing and externalizing scores. Teachers' ratings
ofchildren at 11 years ofage were associated
with bone lead levels for a number ofcate-
gories, induding somatic complaints, anxious/
depressed, social and attention problems,
delinquent and aggressive behaviors, and inter-
nalizing and externalizing. Subjects with
higher lead levels had higher scores in self-
reports ofdelinquency at 11 years ofage.
Higher bone lead levels were associated with
an increased risk ofexceeding the dinical score
for impaired attention, aggression, and delin-
quency, and these subjects were more likely to
have worse scores on all items ofthe CBCL
duringthe4-year periodofobservation.
Consequences of Maternal
Cigarette Smoking
A relatively large literature addresses the long-
term consequences of maternal smoking
during pregnancy in the offspring, which have
revealed impairments after control ofpotential
confounding variables. Maternal smoking dur-
ingpregnancy results in decreased birthweight
(371,372), which is itselfa risk factor for later
behavioral and other health problems. It is
therefore notsurprising that maternal smoking
results in deficits in IQ in the offspring
(373,374). Maternal smoking was also associ-
ated with increased aggressive behavior, as well
as oppositional and overactive behavior in
1,377 twin pairs 3yearsofage (375). Maternal
cigarette smoking was associated with
increased impulsivity (commission errors) on a
continuous performance vigilance task in chil-
dren 6 years ofage (376). Fergusson et al.
(377) observed a correlation between maternal
cigarette smoking and an increased incidence
ofconduct disorders and depression in adoles-
cents 16-18 years ofage. Other studies have
also found an association between antisocial
behavior and maternal cigarette smoking in
middle childhood (378-380) and adolescence
(381-383). Finally, two recent studies identi-
fied a dose-effect relationship between mater-
nal cigarette smoking and persistent criminal
behavior. In one study (384), an increase in
persistent criminal behavior was observed by
34 years ofage in a cohort of4,169 males, as
ascertained from the Danish National
Criminal Register, with effects observed with
as few as 1-2 cigarettes per daysmoked by the
mother. In a similar study in Finland (385), a
cohort of5,636 males was followed prospec-
tively from 6 months in utero to 28 years of
age. Sons ofmotherswho smokedhad a2-fold
(adjusted) increased riskforviolent or repeated
crimes but not nonviolent crimes. As pointed
out by Fergusson (386), these effects ofmater-
nal cigarette smoking, observed in numerous
studies, are resilient tocontrol forconfounding
variables associated with cigarette smoking.
However, it is interesting to note that in the
Risanen et al. (385) study, maternal smoking
combined with risk factors including teenage
pregnancy, single-parent family, and unwanted
pregnancy increased the odds ratio 9-fold for
violent crime and 14-fold forrepeatedcrime.
Consequences of in Utero
Exposureto Ethanol
In 1973 Jones and Smith (387) provided the
first description in the English literature ofa
distinctive pattern ofabnormalities in babies
born to alcoholic mothers, which they named
fetal alcohol syndrome (FAS). The faces ofthe
children with FAS have a recognizable con-
stellation ofabnormalities, including short
palpebral fissures, a flat midface, indistinct
philtrum and thin upper lip, a low nasal
bridge, short nose, micrognathia, and minor
ear abnormalities, and often also include epi-
canthal folds (388). These children are also
small for their age and may have limb and
cardiac abnormalities. Individuals with FAS
have severe dysmorphogenesis ofthe brain
accompanied bycharacteristic behavioral prob-
lems, including lowered IQand hyperactivity
(389). A continuum ofeffects in humans is
evident as a consequence of in utero alcohol
exposure from relatively mild to severe, with
individuals displaying varying degrees ofthe
behavioral and physical anomalies associated
with FAS. Children who have some butnot all
ofthe features ofFAS are referred to as having
fetal alcohol effects (FAE). Theseeffects ofpre-
natal exposure to ethanol have been replicated
in animal models (390).
A longitudinal study on the effects of in
utero exposure to alcohol has been ongoing in
Seattle, Washington, since 1974-1975, at
which time pregnant women were recruited
into thestudyand questioned about theiralco-
hol intake. Offspring ofmothers consuming
on average one drink per day exhibited neuro-
logical deficits as infants and deficits in mem-
ory, IQ, and school achievement, as well as
attention deficits, increased impulsive behav-
ior, and lack ofcooperation (391-393). At 14
years ofage, children in this cohort whose
mothers drankan average ofone drinkperday
during pregnancy still exhibited increased
behavior/learning deficits (394). Individuals
aged 16-27 with IQ scores in the normal
range also exhibited impairment in tests of
attention, memory, and executive function
(395). Binge drinking (fewer than two drinks/
occasion) by the mothers resulted in a profile
ofadolescentantisocial behavior (394).
The consequences of in utero exposure to
alcohol are associated with other behaviors
that make it difficult for an individual to inte-
grate successfully into society. Further studies
with persons with FAS/FAE identified a
50-60% incidence ofmental health problems,
trouble with the law, and inappropriate sexual
behavior (389,396). In this group ofadoles-
cents, prenatal alcohol exposurewas predictive
ofalcohol use, whereas living in an alcoholic
familywas not (397). In the Seattle cohort, 30
women with FAS/FAE had given birth to a
child by 1997. Ofthese, 57% no longer had
the child in their care, 40% drank during
pregnancy, 17% had children with FAS/FAE,
and an additional 13% had children with sus-
pected FAS/FAE. These long-term effects of
FAE represent a human tragedy ofepic pro-
portions, particularly because the estimate of
full-blown FAS is 2.7-4.6 per 1,000 live
births in the United States (388). The finan-
cial and social costs are enormous.
Monetary Consequences of a
"Small" Effect on Cognition
"Small" functional effects often stimulate
intense debate in the risk assessment commu-
nity. A decrement in function that is still con-
sidered to be in the normal range may
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nonetheless have important consequences for a
society, particularly ifa large segment ofthe
society is exposed. It is becoming increasingly
well established that a common effect exposure
to developmental neurotoxicants is a small
decrement in IQ. The consequences ofa shift
in the IQ distribution have been discussed
(398,399). Even a small shift to the left in the
normal distribution has a large effect on the
tails ofthe distribution. For example, a shift in
the IQofthe population by 5 points results in
a doubling ofthe number ofindividuals with
IQs < 70 who would require greater educa-
tional resources in addition to other social sup-
ports. There would be a concomitant decrease
in individuals with IQs > 130 by a factor of
2.5. There is also considerable evidence that
there is a high correlation among IQ, educa-
tion, and lifetime earnings. One ofthe most
powerful and extensive databases is the govern-
ment-funded National Longitudinal Survey of
Youth (NLSY) (400), which has followed
more than 12,000 young people from 3,000
households, now in their 30s, since 1979.
Murray (401) used the NLSY database to cal-
culate the consequences ofchildhood IQ to
later earnings. He identified 710 sibling pairs
in which one had a typical IQ (normal,
90-1 10) and one had an IQ either > 110
(bright) or < 90 (dull). He found that higher
IQwas associated with higher incomes (Figure
17), more education, fewer total offspring, and
Figure 17. Earnings of paired siblings in which one sib-
ling was labeled normal" ( 90110) and the other
was either "bright` (I> 110) or "dull (D < 90) based
on the National Longitudinal Study of Youth (400).
Adapted from Murray (401).
fewer offspring outside marriage. Whatever the
cause of the IQ decrement (genetic and/or
environmental, with exposure to a neurotoxic
agent potentially contributing to both cate-
gories), the consequences have important
implications forsociety.
The monetary cost associated with the
ubiquitous exposure offetuses and children to
lead in industrialized societies has been calcu-
lated by Schwartz (402) in an estimation of
the benefits of a 1-pg/dL reduction in the
population mean blood lead concentration.
The analysis was based on the monetary sav-
ings ofreducing lead levels in children with
blood lead concentrations between 10 and 20
pg/dL. Note that a 1-pg/dL reduction in
blood lead concentrations would result in a
shift in the population of< 1 IQ point based
on meta-analyses (403,404). Schwartz (402)
estimated medical costs associated with treat-
ment ofchildren with undue lead exposure,
the increase in remedial education, and the
costs associated with reduced birth weight and
reduced gestational age, among other factors.
The largest single cost was lost earnings as a
result of decreased intellectual capability:
$5.06 billion in 1994 dollars. The total cost,
including increased medical care, compen-
satory education, and neonatal mortality and
morbidity, was $6.94 billion 1994 dollars. In
a later similar analysis using the NLSY data-
base (400) to monetize the effect ofdecreased
cognitive ability on earning capacity, the esti-
mated gain in earnings was $7.5 billion U.S.
peryear for a decrease in blood lead levels of 1
pg/dL in the U.S. population (405). It is obvi-
ous that the small effect of lead on IQ is
reflected in an enormous cost to society in lost
potential and increased need for medical care
and special education.
A similar analysis has been performed with
respect to the societal cost ofin uteroexposure
to cocaine (406). It is estimated that between
45,000 and 875,000 cocaine-exposed children
are born in the United States each year. Lester
et al. (406) performed a meta-analysis of
studies ofschool-age children and calculated
the effects of cocaine exposure on IQ and
receptive and expressive language abilities
(Table 2). The meta-analysis estimated a 3.26-
point drop in IQ as a result ofprenatal expo-
sure, which would increase by 1.6 times the
number of children with IQs < 70 (2 SDs
below the mean IQ) for a cost ofbetween $4
and 35 million dollars/year for special educa-
tion, whereas children with an IQof< 78 (1.5
SD below the mean) would cost between $10
and 80 million/year. The effect on language is
even greater than that on IQ (as measured by
effect size) and would result in additional
total costs of $33-272 million/year. So,
although the early concerns that cocaine-
exposed babies would suffer from overt brain
damage and intellectual impairment never
materialized, the monetary cost of the more
subtle impairment identified in these children
is still enormous based on increased needs for
educational intervention alone. Lester et al.
(406) did not estimate costs of attentional,
behavioral, or emotional problems, the cost
of decreased earnings, or the possibility of
antisocial behavior during adulthood.
Summary
It is important to reiterate that the nervous
system develops over a very long period of
time extending from the embryonic period
through puberty, with both synaptogenesis
and myelination continuing through puberty
in both animals and humans. Even during
adulthood there is continued recapitulation of
synaptogenesis in the form ofsynaptic plastic-
ity. This plasticity is modified by experience
and environmental stimuli and continues to
play a role in synaptic remodeling in both the
developing and adult nervous system and is
believed to underlie the efficacy and strength
ofsynaptic transmission. Many agents can
cause developmental neurotoxicity as a result
ofalterations in the developmental processes
we have reviewed in this article. The actual
mechanisms by which these processes are per-
turbed by vastly different chemical classes is
an enigma and a continued research question.
However, identification ofperturbations of
these developmental processes by xenobiotics
and clinical disorders has led us to the recog-
nition that a developmental insult can initiate
Table 2. Societal burden of prenatal cocaine exposure.
Percent < 2 SD Additional Additional Percent < 1.5 SD Additional Additional cost
(normal = affected children costfor (normal = affected children for services
Measure Effect(SE) 2.28%) Increase peryear(n) services (millions) 6.68%) Increase peryear(n) (millions)
IQdifference 3.26 (2.01) 3.75 1.6 x 1,688-14,062 $4-35 10.03 1.5 x 4,514-37,612 $10-80
ID points
IQeffectsize 0.33(0.13) 4.75 2.0x 2,138-17,812 $7-59 12.10 1.8x 5,445-45,375 $15-129
SD units
Receptive language 0.71 (0.26) 9.85 4.3 x 4,432-36,938 $22-180 21.48 3.2 x 9,666-80,550 $42-352
effect size SD units
Expressive language 0.60 (0.29) 8.08 3.5 x 3,636-30,300 $17-138 18.14 2.7 x 8,163-68,025 $33-272
effect size SD units
The calculations for children with lQs < 2 SD are included in the calculations for < 1.5 SD. Both calculations are provided because in some cases special education services are provided to children begin-
ning at 1.5 SD below the mean (IQ <78) and sometimes at 2 SD (IQ <70). Adapted from Lester etal. (406).
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a cascade of alterations which may not be
detected structurally or functionally until
much later in life. Thus, these effects may be
manifested at a time much removed from the
critical developmental window when the
exposure occurred. The developmental effects
may be manifested as persistent deficits, devel-
opmental delays, or transient deficits.
Developmental delays and transient deficits in
these developmental processes and ontogeny
offunction may have more insidious conse-
quences later in life. These two types ofeffects
may result from the continued growth and
differentiation ofthe nervous system resulting
in apparent compensation. Such apparent
recovery may be reversed during aging, when
the compensatory ability ofthe nervous sys-
tem may be significantly reduced. The critical
nature oftime ofassessment for adverse effects
after developmental perturbations may extend
into aging because many structures of the
brain (e.g., temporal lobe ofthe cerebral cor-
tex) undergo age-related neuronal loss and
concomitant loss ofsynaptic inputs and/or
plasticity. In addition to latent neurotoxicity
as a consequence ofdevelopmental exposure,
there are tremendous impacts on society of
small effects on function that may impair
either cognitive or social performance (i.e.,
impulsivity, emotionality, and executive func-
tion) in individuals. The societal impact of
these small or transient effects on the popula-
tion can be tremendous when amortized
across the population. These effects can result
in an increased need for remedial assistance in
school, increased medical care, increased assis-
tance later in life with basic life skills, or
increased mortality and morbidity during
aging. These long-term consequences after
developmental exposure to environmental
agents require attention to the neurobiological
substrates and processes that are homologous
between animals and humans and which may
be perturbed byenvironmental agents.
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